Short description:
Contact us to add description: recruit@workinbiotech.com
Drug notes:
Contact us to add description: recruit@workinbiotech.com
Long description:
Palvella Therapeutics is creating treatments for patients with genetic skin diseases. There are many challenges to topical delivery of drugs including skin penetration and the biochemical properties of the drug. Using their QTORIN platform, Palvella is overcoming these topical delivery challenges for a range of cargoes deep into the skin epidermis or dermis. Currently, Palvella has several programs, including QTORIN rapamycin 3.9$ and PTX-014 use the QTORIN technology to deliver the active cargo directly to the site of genetic pathology of each disease. Palvella’s approach has the potential to be applied for various drugs and diseases, including single agents or fixed combinations.